Fresh analysis indicates that individuals who discontinue new slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise regimens.
Research printed in a major medical journal points out that while overweight individuals can lose about a fifth of their body weight while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Users buying such treatments must be cognizant of the potential of quick rebound weight gain when the therapy ends," cautioned lead investigator Dr. Susan Jebb.
That rate of recovery suggests a return to starting weight within about 18 months.
Comparing Therapies
The study, which looked at dozens of trials involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with older methods.
Scientists emphasize that individuals who lose weight through lifestyle changes alone usually see a more gradual weight regain—perhaps 100 grams monthly—once they finish.
Understanding the Rapid Regain
Nutrition scientists believe the mechanism of the injections explains the accelerated weight return.
The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone concentrations far above than the body's typical production may cause the body to produce less of its endogenous GLP-1, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' results in hunger is uncontrolled, making excessive eating a significant risk."
An Ongoing Condition?
Health authorities recommend the jabs for individuals with obesity-related health risks, alongside recommended lifestyle changes.
Professionals say that, due to the high risk of relapse, the therapy should be considered long-term.
This perspective is echoed by pharmaceutical companies, who state that the findings "emphasize the chronic character of excess weight," comparing it to managing conditions like high blood pressure.
Patient Experiences
People who have come off the medication report a intense resurgence of cravings.
"I experienced a switch flipping and you become ravenous," said an individual.
This difficulty is exacerbated if users have not adopted sustainable dietary or behavioural changes during treatment.
Significant Use
Recent estimates indicate that a significant number of people in the UK have tried these injections in the past year, with desire continuing to grow.
- Use is more common among women compared to men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the drugs through private healthcare rather than public health services.
Ultimately, researchers stress that while these medications are effective tools for weight loss, they are not a permanent solution and long-term success hinges on ongoing behavioural management.
